RadNet, Inc.
RDNT
Κατάταξη σε μετοχές
#3235
RadNet, Inc. operates as a prominent healthcare services company specializing... RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Τιμή μετοχής
$69.77
Τελευταίος συγχρονισμός: 2026-10-20
Κεφαλαιοποίηση
$5.49B
Αλλαγή (1 ημέρα)
0.72%
Αλλαγή (1 έτος)
-12.96%
Χώρα
US
Εμπόριο RadNet, Inc. (RDNT)
Κατηγορία
Healthcare
Έσοδα για την RadNet, Inc. (RDNT)
Έσοδα τον Jun 2026 TTM: $2.27B
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της RadNet, Inc., τα τρέχοντα έσοδα της εταιρείας (TTM) είναι $2.27B. Το 2023, η εταιρεία είχε έσοδα $1.62B αύξηση σε σχέση με τα έσοδα του έτους 2022, τα οποία ήταν $1.43B. Τα έσοδα είναι το συνολικό ποσό που παράγει μια εταιρεία από τις πωλήσεις προϊόντων ή υπηρεσιών. Σε αντίθεση με τα κέρδη, δεν αφαιρούνται έξοδα.
Ιστορικό εσόδων για την RadNet, Inc. από 2000 έως 2026
Έσοδα στο τέλος κάθε έτους
| Έτος | Έσοδα | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $2.27B | 24.01% |
| 2024 | $1.83B | 13.18% |
| 2023 | $1.62B | 13.05% |
| 2022 | $1.43B | 8.74% |
| 2021 | $1.32B | 22.69% |
| 2020 | $1.07B | -7.13% |
| 2019 | $1.15B | 18.36% |
| 2018 | $975.15M | 5.74% |
| 2017 | $922.19M | 4.26% |
| 2016 | $884.54M | 9.25% |
| 2015 | $809.63M | 12.83% |
| 2014 | $717.57M | 2.07% |
| 2013 | $702.99M | 8.63% |
| 2012 | $647.15M | 4.41% |
| 2011 | $619.80M | 12.99% |
| 2010 | $548.54M | 4.61% |
| 2009 | $524.37M | 4.43% |
| 2008 | $502.12M | 18.01% |
| 2007 | $425.47M | 164.26% |
| 2006 | $161.01M | 10.60% |
| 2005 | $145.57M | 6.04% |
| 2004 | $137.28M | -2.13% |
| 2003 | $140.26M | 0.70% |
| 2002 | $139.28M | 24.54% |
| 2001 | $111.84M | 27.14% |
| 2000 | $87.96M | 0.00% |
Έσοδα για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Έσοδα | Διαφορά Εσόδων | Χώρα |
|---|---|---|---|
| $46.34B | 1,942.19% |
US
|
|
| $25.11B | 1,006.56% |
US
|
|
| $2.71B | 19.31% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 224.91% |
US
|
